Literature DB >> 17632456

Solid pseudopapillary neoplasms of the pancreas show an interruption of the Wnt-signaling pathway and express gene products of 11q.

Katharina Tiemann1, Ulrike Heitling, Markus Kosmahl, Günter Klöppel.   

Abstract

Solid pseudopapillary neoplasms of the pancreas almost consistently show a beta-catenin mutation activating the Wnt-signaling pathway, resulting in overexpression of cyclin D1, but not in overt malignancy of this tumor. Besides cyclin D1, a set of markers (ie FLI-1, CD56 and progesterone receptor), whose genes map to chromosome 11q, are frequently expressed in solid pseudopapillary neoplasms. Chromosome 11q is a region that is also often affected in pancreatic neuroendocrine tumors. This immunohistochemical study was undertaken to gain insights into the downstream regulation of the Wnt-signaling pathway and the significance of overexpressed gene products belonging to chromosome 11q for the tumorigenesis in solid pseudopapillary neoplasms. Fourteen solid pseudopapillary neoplasms were analyzed for the expression of cyclin-dependent kinase inhibitors p21, p27, p16 and hyperphosphorylated retinoblastoma (pRb) proteins. In an extended series of 93 solid pseudopapillary neoplasms, beta-catenin, cyclin D1, FLI-1 and CD56 expression was examined and compared with that in 22 pancreatic neuroendocrine tumors. Solid pseudopapillary neoplasms (98%) showed aberrant expression of beta-catenin with a concomitant cyclin D1 expression in 69% of the cases, but no expression of pRb (0%) was found. p27 and p21 were expressed in 100% (14/14) and 86% (12/14) of the cases, but only 2/14 (14%) were positive for p16. FLI-1 was expressed in 63% of solid pseudopapillary neoplasms, but only in 1/22 pancreatic neuroendocrine tumors (5%), cyclin D1 expression was present in 14% of the latter. We conclude that in solid pseudopapillary neoplasms the activated Wnt-signaling pathway is disrupted, and that p21 and p27 are contributing to this fact by blocking of the hyperphosphorylation of the Rb protein, thus causing the very low proliferation rate characterizing the solid pseudopapillary neoplasms. The accumulation of high expression of proteins whose genes are located on chromosome 11q is characteristic of solid pseudopapillary neoplasms, but not of pancreatic neuroendocrine tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17632456     DOI: 10.1038/modpathol.3800902

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  15 in total

1.  Overexpression of lymphoid enhancer-binding factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas.

Authors:  Aatur D Singhi; Mhammed Lilo; Ralph H Hruban; Kristi L Cressman; Kimberly Fuhrer; Raja R Seethala
Journal:  Mod Pathol       Date:  2014-03-21       Impact factor: 7.842

2.  Does Computed Tomography Have the Ability to Differentiate Aggressive From Nonaggressive Solid Pseudopapillary Neoplasm?

Authors:  Ashita Rastogi; Mathew Assing; Mellisa Taggart; Brinda Rao; Jia Sun; Khaled Elsayes; Eric Tamm; Priya Bhosale
Journal:  J Comput Assist Tomogr       Date:  2018 May/Jun       Impact factor: 1.826

Review 3.  Solid Pseudopapillary Neoplasms of the Pancreas: A Surgical and Genetic Enigma.

Authors:  Leon Naar; Despoina-Amalia Spanomichou; Aikaterini Mastoraki; Vassilios Smyrniotis; Nikolaos Arkadopoulos
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

4.  The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.

Authors:  Dita Gratzinger; Shuchun Zhao; Robert West; Robert V Rouse; Hannes Vogel; Elena Cubedo Gil; Ronald Levy; Izidore S Lossos; Yasodha Natkunam
Journal:  Am J Clin Pathol       Date:  2009-02       Impact factor: 2.493

Review 5.  Molecular biology of pancreatic cancer.

Authors:  Cristóbal Belda-Iniesta; Immaculada Ibáñez de Cáceres; Jorge Barriuso; Javier de Castro Carpeño; Manuel González Barón; Jaime Feliú
Journal:  Clin Transl Oncol       Date:  2008-09       Impact factor: 3.405

6.  Solid pseudopapillary tumor of the pancreas and concomitant urogenital malformations in a young woman.

Authors:  Zhi-Wei Guan; Lu Sun; Yan-Qiu Wang; Bai-Xuan Xu
Journal:  Diagn Pathol       Date:  2013-02-27       Impact factor: 2.644

7.  BCL9L expression in pancreatic neoplasia with a focus on SPN: a possible explanation for the enigma of the benign neoplasia.

Authors:  Cora Hallas; Julia Phillipp; Lukas Domanowsky; Bettina Kah; Katharina Tiemann
Journal:  BMC Cancer       Date:  2016-08-18       Impact factor: 4.430

8.  Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61.

Authors:  Makoto Sano; David R Driscoll; Wilfredo E DeJesus-Monge; Brian Quattrochi; Victoria A Appleman; Jianhong Ou; Lihua Julie Zhu; Nao Yoshida; Shintaro Yamazaki; Tadatoshi Takayama; Masahiko Sugitani; Norimichi Nemoto; David S Klimstra; Brian C Lewis
Journal:  Neoplasia       Date:  2016-11-25       Impact factor: 5.715

Review 9.  Surgical and molecular pathology of pancreatic neoplasms.

Authors:  Wenzel M Hackeng; Ralph H Hruban; G Johan A Offerhaus; Lodewijk A A Brosens
Journal:  Diagn Pathol       Date:  2016-06-07       Impact factor: 2.644

10.  Identification of potential biomarkers to differentially diagnose solid pseudopapillary tumors and pancreatic malignancies via a gene regulatory network.

Authors:  Pengping Li; Yuebing Hu; Jiao Yi; Jie Li; Jie Yang; Jin Wang
Journal:  J Transl Med       Date:  2015-11-14       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.